Skip to main content
Fig. 1 | BMC Pulmonary Medicine

Fig. 1

From: Long-term multicenter comparison shows equivalent efficacy of monoclonal antibodies in severe asthma therapy

Fig. 1

A-F Time course of ACT (A), Annualized exacerbation rate (B), FEV1% (C), RV% (D), Eosinophils (E) and oral corticosteroid dose (F). Notes: Graphs represent measurements per parameter and treatment group at baseline, T1 and T2 from left to right. Dark line indicates median, box indicates interquartile range, whiskers indicate minimum and maximum values. Abbreviations: BL – baseline, T1 – timepoint 1 (6 months), T2 – timepoint 2 (12 months), FEV1 (%) – percentage of forced expiratory capacity in 1 s compared to calculated normal, RV – percentage of residual volume compared to calculated normal, ACT – asthma control test, OCS – oral corticosteroids

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us